EA GETBO 3878, University Hospital of Brest, Brest, France
Search for other papers by Philippe Thuillier in
Google Scholar
PubMed
EA GETBO 3878, University Hospital of Brest, Brest, France
Search for other papers by Nathalie Roudaut in
Google Scholar
PubMed
EA GETBO 3878, University Hospital of Brest, Brest, France
Search for other papers by Geneviève Crouzeix in
Google Scholar
PubMed
Department of Nuclear Medicine, University Hospital of Brest, Brest, France
Search for other papers by Marie Cavarec in
Google Scholar
PubMed
Department of Nuclear Medicine, University Hospital of Brest, Brest, France
Search for other papers by Philippe Robin in
Google Scholar
PubMed
Department of Nuclear Medicine, University Hospital of Brest, Brest, France
Search for other papers by Ronan Abgral in
Google Scholar
PubMed
EA GETBO 3878, University Hospital of Brest, Brest, France
Search for other papers by Véronique Kerlan in
Google Scholar
PubMed
Department of Nuclear Medicine, University Hospital of Brest, Brest, France
Search for other papers by Pierre-Yves Salaun in
Google Scholar
PubMed
carotid duplex ultrasonography varies from 9.4% to 27.0% ( 1 ). In cervical computed tomography (CT) and magnetic resonance imaging (MRI) scans, studies show a prevalence of TI nearly to 16% ( 2 , 3 ). The common use of 18F-fluorodeoxyglucose (FDG
Search for other papers by Gamze Akkuş in
Google Scholar
PubMed
Search for other papers by Isa Burak Güney in
Google Scholar
PubMed
Search for other papers by Fesih Ok in
Google Scholar
PubMed
Search for other papers by Mehtap Evran in
Google Scholar
PubMed
Search for other papers by Volkan Izol in
Google Scholar
PubMed
Search for other papers by Şeyda Erdoğan in
Google Scholar
PubMed
Search for other papers by Yıldırım Bayazıt in
Google Scholar
PubMed
Search for other papers by Murat Sert in
Google Scholar
PubMed
Search for other papers by Tamer Tetiker in
Google Scholar
PubMed
Erickson D Maraka S Young WF Nathan MA . Diagnostic performance of unenhanced computed tomography and 18F-fluorodeoxyglucose positron emission tomography in indeterminate adrenal tumours . Clinical Endocrinology 2018 88 . ( https://doi.org/10
Search for other papers by Pan Chen in
Google Scholar
PubMed
Search for other papers by Liqin Pan in
Google Scholar
PubMed
Search for other papers by Wensi Huang in
Google Scholar
PubMed
Search for other papers by Huijuan Feng in
Google Scholar
PubMed
Search for other papers by Wei Ouyang in
Google Scholar
PubMed
Search for other papers by Juqing Wu in
Google Scholar
PubMed
Search for other papers by Jing Wang in
Google Scholar
PubMed
Search for other papers by Yuying Deng in
Google Scholar
PubMed
Search for other papers by Jiaxin Luo in
Google Scholar
PubMed
Search for other papers by Yanying Chen in
Google Scholar
PubMed
(generally >10 ng/mL) with negative radioiodine imaging and no 18F-fluorodeoxyglucose (18F-FDG) uptake. Following the 131 I therapy, 131 I whole-body scan was performed after 2–7 days, and TSH suppression was implemented for all patients. Follow
Search for other papers by Majunath R Goroshi in
Google Scholar
PubMed
Search for other papers by Swati S Jadhav in
Google Scholar
PubMed
Search for other papers by Anurag R Lila in
Google Scholar
PubMed
Search for other papers by Rajeev Kasaliwal in
Google Scholar
PubMed
Search for other papers by Shruti Khare in
Google Scholar
PubMed
Search for other papers by Chaitanya G Yerawar in
Google Scholar
PubMed
Search for other papers by Priya Hira in
Google Scholar
PubMed
Search for other papers by Uday Phadke in
Google Scholar
PubMed
Search for other papers by Hina Shah in
Google Scholar
PubMed
Search for other papers by Vikram R Lele in
Google Scholar
PubMed
Search for other papers by Gaurav Malhotra in
Google Scholar
PubMed
Search for other papers by Tushar Bandgar in
Google Scholar
PubMed
Search for other papers by Nalini S Shah in
Google Scholar
PubMed
I Chen CC Carrasquillo JA Whatley M Nieman LK. The role of [(18)F]fluorodeoxyglucose positron emission tomography and [(111)In]-diethylenetriaminepentaacetate-D-Phe-pentetreotide scintigraphy in the localization of ectopic
Search for other papers by Keiko Ohkuwa in
Google Scholar
PubMed
Search for other papers by Kiminori Sugino in
Google Scholar
PubMed
Search for other papers by Mitsuji Nagahama in
Google Scholar
PubMed
Search for other papers by Wataru Kitagawa in
Google Scholar
PubMed
Search for other papers by Kenichi Matsuzu in
Google Scholar
PubMed
Search for other papers by Akifumi Suzuki in
Google Scholar
PubMed
Search for other papers by Chisato Tomoda in
Google Scholar
PubMed
Search for other papers by Kiyomi Hames in
Google Scholar
PubMed
Search for other papers by Junko Akaishi in
Google Scholar
PubMed
Search for other papers by Chie Masaki in
Google Scholar
PubMed
Search for other papers by Koichi Ito in
Google Scholar
PubMed
follows: (i) no accumulation of RAI, (ii) tumor growth even with little accumulation of RAI, and (iii) tumor growth after RAI therapy (≥ 600 mCi). Based on the American Thyroid Association Guidelines, 18F-fluorodeoxyglucose PET/CT (18FDG-PET/CT), whole
Clinic for Nuclear Medicine, University Hospital of Zürich, Zürich, Switzerland
Search for other papers by Luca Giovanella in
Google Scholar
PubMed
Search for other papers by Maria Luisa Garo in
Google Scholar
PubMed
Search for other papers by Domenico Albano in
Google Scholar
PubMed
Search for other papers by Rainer Görges in
Google Scholar
PubMed
Faculty of Biomedical Sciences, Institute of Oncology Research, Università della Svizzera Italiana, Bellinzona, Switzerland
Search for other papers by Luca Ceriani in
Google Scholar
PubMed
relationship with demographic-histopathologic risk factors and (18)F-fluorodeoxyglucose positron emission tomography/computed tomography parameters . Cancer Biotherapy and Radiopharmaceuticals 2021 36 425 – 432 . ( https://doi.org/10.1089/cbr.2019.3203 ) 6
Turku PET Centre, University of Turku, Turku, Finland
Search for other papers by Jukka Koffert in
Google Scholar
PubMed
Search for other papers by Henri Honka in
Google Scholar
PubMed
Search for other papers by Jarmo Teuho in
Google Scholar
PubMed
Search for other papers by Saila Kauhanen in
Google Scholar
PubMed
Search for other papers by Saija Hurme in
Google Scholar
PubMed
Department of Radiology, University of Turku and Turku University Hospital, Turku, Finland
Search for other papers by Riitta Parkkola in
Google Scholar
PubMed
Search for other papers by Vesa Oikonen in
Google Scholar
PubMed
Search for other papers by Andrea Mari in
Google Scholar
PubMed
Search for other papers by Andreas Lindqvist in
Google Scholar
PubMed
Search for other papers by Nils Wierup in
Google Scholar
PubMed
Search for other papers by Leif Groop in
Google Scholar
PubMed
Department of Endocrinology, Turku University Hospital, Turku, Finland
Search for other papers by Pirjo Nuutila in
Google Scholar
PubMed
. Clinical Science 2012 122 375 – 384 . ( doi:10.1042/CS20090464 ) 12 Honka H Makinen J Hannukainen JC Tarkia M Oikonen V Teras M Fagerholm V Ishizu T Saraste A Stark C Validation of [18F]fluorodeoxyglucose and
Search for other papers by Sanjeet Kumar Jaiswal in
Google Scholar
PubMed
Search for other papers by Vijaya Sarathi in
Google Scholar
PubMed
Search for other papers by Saba Samad Memon in
Google Scholar
PubMed
Search for other papers by Robin Garg in
Google Scholar
PubMed
Search for other papers by Gaurav Malhotra in
Google Scholar
PubMed
Search for other papers by Priyanka Verma in
Google Scholar
PubMed
Search for other papers by Ravikumar Shah in
Google Scholar
PubMed
Search for other papers by Manjeet Kaur Sehemby in
Google Scholar
PubMed
Search for other papers by Virendra A Patil in
Google Scholar
PubMed
Search for other papers by Swati Jadhav in
Google Scholar
PubMed
Search for other papers by Anurag Ranjan Lila in
Google Scholar
PubMed
Search for other papers by Nalini S Shah in
Google Scholar
PubMed
Search for other papers by Tushar R Bandgar in
Google Scholar
PubMed
Young H , Baum R , Cremerius U , Herholz K , Hoekstra O , Lammertsma AA , Pruim J & Price P . Measurement of clinical and subclinical tumour response using [18F] fluorodeoxyglucose and positron emission tomography: review and
Department of Neuroscience DNS, University of Padova, Padova, Italy
Search for other papers by Filippo Ceccato in
Google Scholar
PubMed
Nuclear Medicine Unit, Department of Medicine – DIMED, University-Hospital of Padova, Padova, Italy
Padova Neuroscience Center PNC, University of Padova, Padova, Italy
Search for other papers by Diego Cecchin in
Google Scholar
PubMed
Search for other papers by Michele Gregianin in
Google Scholar
PubMed
Search for other papers by Giacomo Ricci in
Google Scholar
PubMed
Department of Mathematics ‘Tullio Levi-Civita’ DM, University of Padova, Padova, Italy
Search for other papers by Cristina Campi in
Google Scholar
PubMed
Search for other papers by Filippo Crimì in
Google Scholar
PubMed
Search for other papers by Marta Bergamo in
Google Scholar
PubMed
Search for other papers by Annibale Versari in
Google Scholar
PubMed
Search for other papers by Carmelo Lacognata in
Google Scholar
PubMed
Search for other papers by Federico Rea in
Google Scholar
PubMed
Search for other papers by Mattia Barbot in
Google Scholar
PubMed
Search for other papers by Carla Scaroni in
Google Scholar
PubMed
-secreting neoplasm in 44% of covert EAS ( 10 ). In patients with negative CT and/or MR, nuclear medicine improves the sensitivity of conventional radiology: a positive finding is described in 67% of 111 In-Octreoscan and in 60% of 18 F-fluorodeoxyglucose ( 18 F
Search for other papers by Weixi Wang in
Google Scholar
PubMed
Search for other papers by Rulai Han in
Google Scholar
PubMed
Search for other papers by Lei Ye in
Google Scholar
PubMed
Search for other papers by Jing Xie in
Google Scholar
PubMed
Search for other papers by Bei Tao in
Google Scholar
PubMed
Search for other papers by Fukang Sun in
Google Scholar
PubMed
Search for other papers by Ran Zhuo in
Google Scholar
PubMed
Search for other papers by Xi Chen in
Google Scholar
PubMed
Search for other papers by Xiaxing Deng in
Google Scholar
PubMed
Search for other papers by Cong Ye in
Google Scholar
PubMed
Search for other papers by Hongyan Zhao in
Google Scholar
PubMed
Search for other papers by Shu Wang in
Google Scholar
PubMed
position test was normal. Ultrasound revealed a 14 cm mass in the left adrenal gland and renal compression. To exclude malignant diseases, we performed abdominal CT, bone scan and 18 F-fluorodeoxyglucose positron emission tomography-computed tomography